What Is Cytoreductive Nephrectomy?
Eric A. Singer, MD, MA, FACS Assistant Professor of Surgery and Radiology Director, Kidney Cancer Program Rutgers Cancer Institute of New Jersey discusses What Is Cytoreductive Nephrectomy? At Kidney ...
Author: kidneycancer
Added: 10/04/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 4, 2018 Category: Cancer & Oncology Source Type: podcasts
Role of Cytoreductive Nephrectomy in Metastatic RCC
Eric A. Singer, MD, MA, FACS Assistant Professor of Surgery and Radiology Director, Kidney Cancer Program Rutgers Cancer Institute of New Jersey discusses the Role of Cytoreductive Nephrectomy in Meta...
Author: kidneycancer
Added: 10/04/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 4, 2018 Category: Cancer & Oncology Source Type: podcasts
Cytoreductive Nephrectomy Viable Today
Eric A. Singer, MD, MA, FACS Assistant Professor of Surgery and Radiology Director, Kidney Cancer Program Rutgers Cancer Institute of New Jersey discusses Cytoreductive Nephrectomy Viable Today at Kid...
Author: kidneycancer
Added: 10/04/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 4, 2018 Category: Cancer & Oncology Source Type: podcasts
Carmena Trial Results In Kidney Cancer
Eric A. Singer, MD, MA, FACS Assistant Professor of Surgery and Radiology Director, Kidney Cancer Program Rutgers Cancer Institute of New Jersey discusses Carmena Trial Results In Kidney Cancer at Kid...
Author: kidneycancer
Added: 10/04/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 4, 2018 Category: Cancer & Oncology Source Type: podcasts
Risk Of New Tumor Developing
Brian Shuch, MD Associate Professor of Urology at UCLA Discusses the Risk Of New Tumor Developing at Kidney Cancer Association National Patient and Caregiver Conference Chicago, IL on September 22, ...
Author: kidneycancer
Added: 10/04/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 4, 2018 Category: Cancer & Oncology Source Type: podcasts
Treatment Of The Incidental Renal Mass
Brian Shuch, MD Associate Professor of Urology at UCLA Discusses the Treatment Of The Incidental Renal Mass at Kidney Cancer Association National Patient and Caregiver Conference Chicago, IL on Sept...
Author: kidneycancer
Added: 10/04/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 4, 2018 Category: Cancer & Oncology Source Type: podcasts
Surgery In Kidney Cancer
E Jason Abel, MD FACS University of Wisconsin School of Medicine and Public Health discusses Surgery in kidney cancer at Kidney Cancer Association National Patient and Caregiver Conference Chicago, ...
Author: kidneycancer
Added: 10/04/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 4, 2018 Category: Cancer & Oncology Source Type: podcasts
Higher Risk Of Occurrence In Non-Metastatic RCC
E Jason Abel, MD FACS University of Wisconsin School of Medicine and Public Health Discusses the Higher Risk Of Occurrence In Non-Metastatic RCC at Kidney Cancer Association National Patient and Careg...
Author: kidneycancer
Added: 10/04/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 4, 2018 Category: Cancer & Oncology Source Type: podcasts
Complex Surgery Locally Advanced Kidney Cancer
E Jason Abel, MD FACS University of Wisconsin School of Medicine and Public Health discusses the Complex Surgery Locally Advanced Kidney Cancer at Kidney Cancer Association National Patient and Caregi...
Author: kidneycancer
Added: 10/04/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 4, 2018 Category: Cancer & Oncology Source Type: podcasts
Novel drugs for patients with renal cell carcinoma
Here, Francesco Montorsi, MD, from Vita-Salute San Raffaele University, Milan, Italy, speaks at the 2018 Genitourinary Cancers Symposium, held in San Francisco, CA, about how the outcome of patients w...
Author: VJOncology
Added: 09/07/2018 (Source: Oncology Tube)
Source: Oncology Tube - September 7, 2018 Category: Cancer & Oncology Source Type: podcasts
The agents at the forefront of kidney cancer treatment
Speaking from the 2018 Genitourinary Cancers Symposium, held in San Francisco, CA, Michael Atkins, MD, of Georgetown University, Washington, DC, outlines the changing landscape of kidney cancer, expla...
Author: VJOncology
Added: 09/07/2018 (Source: Oncology Tube)
Source: Oncology Tube - September 7, 2018 Category: Cancer & Oncology Source Type: podcasts
Success of novel immunotherapies for renal cell carcinoma
At the Genitourinary Cancers Symposium 2018 in San Francisco, CA, recent therapeutic developments for renal cell carcinoma (RCC) were discussed by Jeanny Aragon-Ching, MD, FACP, of Inova Schar Cancer ...
Author: VJOncology
Added: 09/07/2018 (Source: Oncology Tube)
Source: Oncology Tube - September 7, 2018 Category: Cancer & Oncology Source Type: podcasts
Promising results for axitinib and pembrolizumab in advanced renal cell cancer
Michael Atkins, MD, of Georgetown University, Washington DC, outlines the results of the study of VEGF inhibitor axitinib in combination with pembrolizumab for the first-line treatment of advanced ren...
Author: VJOncology
Added: 09/06/2018 (Source: Oncology Tube)
Source: Oncology Tube - September 6, 2018 Category: Cancer & Oncology Source Type: podcasts
Exciting potential of pembrolizumab combined with axitinib for kidney cancer
Elizabeth Plimack, MD, from Fox Chase Cancer Center, Philadelphia, PA, gives an overview of a study (NCT02133742) looking at pembrolizumab combined with axitinib for the first-line treatment of advanc...
Author: VJOncology
Added: 09/06/2018 (Source: Oncology Tube)
Source: Oncology Tube - September 6, 2018 Category: Cancer & Oncology Source Type: podcasts
Combining immunotherapy with VEGF inhibitors to treat kidney cancer
Speaking from the 2018 Genitourinary Cancers Symposium, held in San Francisco, CA, Michael Atkins, MD, of Georgetown University, Washington, DC, tells us about the potential benefits of combining immu...
Author: VJOncology
Added: 09/06/2018 (Source: Oncology Tube)
Source: Oncology Tube - September 6, 2018 Category: Cancer & Oncology Source Type: podcasts
